AZ-Air - website for respiratory experts
  










Please enter your user name and
password.

User name:

Password:





Forgot your
password?


Do not have a password?






FAQ

 Contact us

Legal notice




International website for respiratory experts


Bambec is at least as effective as oral terbutaline, salbutamol, and theophylline, with the advantage of convenient once-daily dosing.

1.  Persson G et al. Curr Ther Res 1995; 56: 457–65 
 
2.  Gunn SD, et al. Eur J Clin Pharmacol 1995; 48: 23–8 
 
3.  Bone MF, et al. Eur Respir J 1995; 8 (Suppl. 19): 72S  





1. Persson G et al. Curr Ther Res 1995; 56: 457–65
 
Bambec 20 mg once daily and terbutaline 5 mg three-times daily produced similar improvements in lung function (measured by PEF values) but Bambec caused better overall improvement in asthma symptom scores and less uneasiness.

Efficancy of Bambec: asthma symptom scores Bambec versus terbutaline

Adapted from Persson et al., 1995.

Side-effect profile of Bambec: adverse event scores Bambec versus terbutaline

Adapted from Persson et al., 1995.
 
2. Gunn SD, et al. Eur J Clin Pharmacol 1995; 48: 23–8
 
Bambec 20 mg once daily and salbutamol CR 8 mg twice daily were equally effective in controlling nocturnal asthma symptoms and improving lung function measurements. Bambec was associated with significantly less tremor than salbutamol CR.

Efficacy of Bambec: sleep disturbance in asthma Bambec versus salbutamol

Adapted from Gunn et al., 1995

Side-effect profile of Bambec: tremor scores Bambec versus salbutamol

Adapted from Gunn et al., 1995.
 
3. Bone MF, et al. Eur Respir J 1995; 8 (Suppl. 19): 72S
 
This study compared Bambec with sustained release theophylline. Following a run-in period, patients received theophylline twice daily at 150 mg for 4 days, then 300 mg for 10 days, or Bambec once daily at 10 mg for 4 days and 20 mg for 10 days (Period I). A greater increase in PEF was observed in the Bambec group than in the theophylline group.

In period II, patients continued to receive Bambec 20 mg twice daily or received theophylline 300, 400, or 600 mg optimised to produce a plasma concentration of 10–20 mg/L. Similar increases in PEF were observed.

More patients withdrew from the study due to adverse events in the theophylline group than in the Bambec group (39% versus 14%; p < 0.001).

Efficacy of Bambec: lung function
Bambec versus theophylline


In period I, patients received theophylline twice daily at 150 mg for 4 days, then 300 mg for 10 days, or Bambec once daily at 10 mg for 4 days and 20 mg for 10 days.
Adapted from Bone et al., 1995.
 
back to top
 

Effective bronchodilation over the full 24-hour period 
Reduces diurnal variation in lung function 
Especially effective in patients with nocturnal asthma 
Effective and well tolerated in long-term treatment 
Especially suitable for children 
Suitable for the elderly 
At least as effective as oral terbutaline (t.i.d.), CR salbutamol (b.i.d.), and CR theophylline (b.i.d.) 
At least as effective and well-tolerated as inhaled salmeterol 
A prodrug of the beta2-adrenergic agonist terbutaline 
 
Different formulations of Bambec 
Alternative names for Bambec 
Bibliography 
Prescribing information